The present study examined the potential use of FDA-approved antimicrobial drugs, namely ivermectin, arteether and praziquantel, to combat human cancers via downregulating VEGF and GST signaling using drug repurposing, molecular docking and MD simulation approaches. The gene discussed is VEGFA; the disease is cancer.